search for




 







Instructions for Authors

Revised on July 2017

  • Journal of Korean Skull Base Society (J Korean Skull Base Soc) is an international, peer-reviewed biannually (30th May and 31th October) journal of medicine published in Korean or English.
    It is the official journal of the Korean Skull Base Society publishes original contributions valuable to the advancement of medical diagnosis and treatment.
    The Journal will contain editorials, review articles, original articles, and case reports. All the authors listed in the manuscript must have prepared according to the following policy and instructions in J Korean Skull Base Soc on submission of manuscript. J Korean Skull Base Soc follows the Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication (http://www.icmje.org/) if not otherwise described below.
    Any physicians or researchers throughout the world can submit a manuscript if the scope of the manuscript is appropriate.
    Only those manuscripts which are original, have not been published elsewhere, and are not currently being considered for inclusion in another publication will be considered for publication in J Korean Skull Base Soc.


  • MANUSCRIPT SUBMISSION

    RESEARCH AND PUBLICATION ETHICS

    Registration of Clinical Trial Research
    • It is recommended that any research that deals with a clinical trial be registered with a primary national clinical trial registration site, such as http://cris.cdc.go.kr/, or other sites accredited by the WHO as listed at http://www.who.int/ictrp/en/.


    Statement of Informed Consent
    • Copies of written informed consent and institutional review board (IRB) approval for clinical research should be kept.
      If necessary, the editor or reviewers may request copies of these documents to resolve questions about IRB approval and study conduct.
      In addition, for studies conducted with human subjects, the method by which informed consent was obtained from the participants (i.e., verbal or written) also needs to be stated in the Methods section.


    Conflict of Interest
    • The corresponding author must inform the editor of any potential conflicts of interest that could influence the authors' interpretation of the data.
      Examples of potential conflicts of interest are financial support from or connections to pharmaceutical companies, political pressure from interest groups, and academically related issues. In particular, all sources of funding applicable to the study should be explicitly stated.
      These conflicts of interest must be included as a footnote on the title page or in the acknowledgement section.


    Authorship
    • Authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data 2) drafting the article or revising it critically for important intellectual content and 3) final approval of the version to be published.
      4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
      Authors should meet these 4 conditions. If the number of authors is greater than six, there should be a list of each author's role for the submitted paper.
      After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or re-arranging the order of authors) must be explained by a letter to the editor from the authors concerned.
      This letter must be signed by all authors on the paper. Copyright assignment must be completed by every author.


    Originality and Duplicate Publication
    • All submitted manuscripts should be original and should not be considered by other scientific journals for publication at the same time.
      No part of the accepted manuscript should be duplicated in any other scientific journal without the permission of the Editorial Board.
      The duplication will be checked through crosscheck (https://app.ithenticate.com/) or eTBLAST (http://etest.vbi.vt.edu/etblast3/) before submission.
      If duplicate publication related to the papers of this journal is detected, the manuscripts may be rejected, the authors will be announced in the journal, and their institutes will be informed.
      There will also be penalties for the authors.
      A letter of permission is required for any and all material that has been published previously. It is the responsibility of the author to request permission from the publisher for any material that is being reproduced.
      This requirement applies to text, illustrations, and tables.


    Secondary Publication
    • It is possible to republish manuscripts if the manuscripts satisfy the conditions of secondary publication of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals.


    PEER REVIEW PROCESS

    • Author’s name and affiliations are removed during peer review, and all manuscripts will be evaluated by two peer reviewers who are selected by the editors. The acceptance criteria for all papers are based on many factors, including the quality and originality of the research and its clinical and scientific significance. An initial decision will normally be made within 3 weeks after the agreement of review by the reviewers, and the reviewers' comments will then be sent to the corresponding authors.
      Revised manuscripts must be submitted online by the corresponding author. The corresponding author must indicate the alterations that have been made in response to the referees' comments item by item in a response note and the submitted original file with tracing. Failure to resubmit the revised manuscript within 8 weeks of the editorial decision is regarded as a withdrawal. The editorial office should be notified if additional time is needed or if an author chooses not to submit a revision. The editorial committee makes decisions concerning editing, revision, and acceptance or rejection, and editing may include shortening an article, reducing the number of illustrations or tables, or changing the paper's format or the order of the manuscript.


    COPYRIGHTS AND CREATIVE COMMONS ATTRIBUTION LICENSE

    • The manuscript, when published, will become the property of the journal. All published papers become the permanent property of the Korean Skull Base Society and must not be published elsewhere without written permission. They also follow the Creative Commons Attribution Non-Commercial License available from: http://creativecommons.org/ licenses/by-nc/3.0/.


    PUBLICATIOIN PROCESSING CHARGES

    • The processing charge, publication fee, print fee, offprint fee (specifying the number of copies on the cover page, the basic 20 copies) is provided. Additional offprint may incur an extra cost.


    MANUSCRIPT PREPARATION


    Publication Type
    • J Korean Skull Base Soc publishes editorials, review articles, original articles, case reports. · Editorials are invited perspectives on an area of skull base, dealing with very active fields of research, current surgical interests, fresh insights, and debates.
      · Review articles provide a concise review of a subject of importance to skull base researchers written by an invited expert in skull base.
      · Original articles are papers reporting the results of basic and clinical investigations that are sufficiently well documented to be acceptable to critical readers.
      · Case reports should be unique, that is, never reported or similar to previously reported cases but with unique characteristics related to location, presenting different symptoms, or using a new diagnosis or management modality.


    General Guidelines
    • J Korean Skull Base Soc publishes editorials, review articles, original articles, case reports. · The manuscript should be written in 12-point font with double line spacing on A4 sized (21.0 × 29.7 cm) paper with 2.5 cm margins on the top, bottom, right, and left.
      · The document should be written in Korean or English, if necessary, Chinese character or the original language can be used in parentheses after Korean.
      · The use of acronyms and abbreviations is discouraged and should be kept to a minimum. When used, they are to be defined where fist used, followed by the acronym or abbreviation in parentheses.
      ·The main document with the manuscript text and tables should be prepared with in an MS Word or RTF format in Korean or English.
      ·Medical terminology used in the manuscript should be written based on the most recent edition of glossary published by Korean Medical Association.
      ·Names of persons and places, and other proper nouns should be used in original language. Numeric characters should be written as Arabic letter.
      ·Drug and chemical names should be stated in standard chemical or generic nomenclature.
      ·Weights and measures should be used as metric system.
      ·Units of measure should be presented according to the International System (SI) of Units. All units must be preceded by one space except angle (°), percentage (%) and temperature (°C).
      ·Descriptions of genes or related structures in a manuscript should include the names and official symbols provided by the US National Center for Biotechnology Information (NCBI) or the HUGO Gene Nomenclature Committee.
      ·Statistical expression: mean and standard deviation should be described as mean ± SD, and mean and standard error as mean ± SE. P-values should be described as P < 0.05 or P = 0.003.
      ·Generic and brand name of medicine: for medicine, use generic names. If a brand name should be used, insert it in parentheses after the generic name.


    Reporting Guidelines for Specific Study Designs


    ORIGINAL ARTICLES

    • Manuscripts will not be acceptable for publication unless they meet the following editorial requirements. Manuscripts must include 1) Title page, 2) Structured abstract and keywords, 3) Main text (Introduction, Materials and Methods, Results, Discussion, Summary or Conclusion), 4) References, 5) Tables, and 6) Figure legends. Each component should begin on a new page in the following sequence.


    Title page
    • The title page should contain the following information in the order listed: 1) Korean title, 2) Name of the institutions at which the work was performed in Korean, 3) All authors were written full name in Korean, 4) English title, 5) Full names of authors in English, 6) The institutional affiliation in English, 7) Full contact information (including name, address, telephone, fax number, and e-mail address) of the corresponding author, 8) The number of copies.


    Abstract and Keywords
    • The abstract should contain the following components: Background, Materials and Methods, Results, and Conclusions. It should not exceed 250 words. Medical Subject Headings (MeSH) authorized words should only be used for the keywords, and a maximum of five keywords should be listed just after the abstract.


    Main Text
    • Introduction: The purpose of the investigation, including relevant background information, should be briefly described.
      Methods: The research plan, the materials (or subjects), and the methods used should be described. If relevant, information on the IRB approval and informed consent should be included. Methods of statistical analysis and criteria for statistical significance should be described.
      Results: The results should be presented in logical sequence in the text, tables, and illustrations. The text should not repeat all the data in the tables or figures, but describe important points and trends.
      Discussion: Discussions about the findings of the research and interpretations in relation to other studies are made. It is necessary to emphasize the new and critical findings of the study, not to repeat the results of the study presented in the previous sections.


    References
    • The authors are responsible for the accuracy of the references. References should be obviously related to the content of the submitted paper. References should be numbered consecutively in the order in which they are first mentioned in the text. Each reference should be cited as [1], [1,4], or [1-3], at the end of the related sentence in the text. The abbreviated journal title should be used according to the List of Journals Indexed for MEDLINE (http://www.ncbi.nlm.nih.gov/nlmcatalog/journals) and the List of KoreaMed Journals (http://www.koreamed.org/JournalBrowser.php). If there are more than six authors, name only the first six authors and then use ‘et al.’. Other types of references not described below should follow Citing medicine: The NLM style guide for authors, editors, and publishers (http://www.ncbi.nlm.nih.gov/books/NBK7256/).


    Examples of Reference style:
    • Journal Article
      1.       Lee JD, Kim CH, Hong SM, Kim SH, Suh MW, Kim MB, et al. Prevalence of vestibular and balance disorders in children and adolescents according to age: A multi-center study. Int J Pediatr Otorhinolaryngol 2017;94:36-9.

      2.       Kang WS, Kim SA, Yang CJ, Nam SH, Chung JW. Surgical outcomes of middle fossa approach in intracanalicular vestibular schwannoma. Acta Otolaryngol 2017;137:352-5.

      3.       Gavid M, Dubois MD, Larivé E, Prades JM. Superior laryngeal nerve in thyroid surgery: anatomical identification and monitoring. Eur Arch Otorhinolaryngol 2017. http://dx.doi.org/10.1007/s00405-017-4666-9.

    • Book
      4.       Jackler RK. Atlas of skull base surgery and neurotology. 2nd ed. New York, NY: Thieme; 2008.

    • Book Chapter
      5.       Ammirati M, Lamki T. Overview of skull base tumors. In: Winn HR, editor. Youmans and Winn neurological surgery. 7th ed. Philadelphia, PA: Elsevier; 2017. p.1222-42.

    • Website
      6.       Welch KC. Skull base anatomy [Internet]. Oak Ridge, NJ: American Rhinologic Society; 2015 [cited 2017 July 12]. Available from: http://care.american-rhinologic.org/skull_base_anatomy.

    Examples of Reference style:
    • Tables should be written in English, and be typed double-spaced on separate pages within manuscript, and they should be titled and numbered in Arabic numerals in the order of their first citation in the text. Each column should be given a short heading. Only the first letter of the first word in each row and column should be capital letters. If numerical measurements are given, the unit of measurement should be included in the column heading. The statistical significance of observed differences in the data should be indicated by the appropriate statistical analysis. All abbreviations should be defined in footnotes. For special remarks, lower case letters in superscripts a), b), c), d), e),.... should be used.

    Figures
    • Figures and figure legends should be written in English, and each figure should be black and white images or color photographs with excellent quality. Authors are responsible for any additional costs of producing color figures. Total file size of all figures should not exceed 5MB. Unless, upload the figures after reducing the file size within 5MB. If your manuscript is accepted for publication, editorial office requests you to upload figure files of highest quality for printing. The files should have following resolutions for printing: line art at 1200 dpi, combination half-tones at 600 dpi, and half-tones (gray scale or color without type or lettering) at 300 dpi, and saved as follows: corresponding author's last name_fig1.jpg, corresponding author's last name_fig1.tif.

    EDITORIAL

    • Editorials are invited by the editor and should be commentaries on articles published recently in the J Korean Skull Base Soc. Editorial topics could include active areas of research, fresh insights, and debates in all fields of skull base.

    CASE REPORT

    • Case reports deal with clinical cases of surgical interest or innovation. Manuscripts include a Title page, Unstructured abstract and Keywords, Introduction, Case Report, Discussion, Summary or Conclusion (if necessary), References, Tables, Figures, and Legends. The case report and idea innovation should not exceed 5 type-written pages, and 4 authors. The abstracts should be unstructured and its length should not exceed 200 words.

    MANUSCRIPTS AFTER ACCEPTANCE

    • Accepted manuscript will be converted to PDF format. The PDF file will be dispatched to the author for proofreading. Any changes should be returned within 48 hours after receipt of the PDF files. No significant changes should be made to alter the interpretation of the results. Only minor changes, such as correcting typographical errors or critical changes to maintain article's accuracy, are allowed. If there are too many changes during the author's proofreading process, those changes will not be accepted and the paper can be considered for re-submission. Authors should do their best to ensure the accuracy of the proofs. After the publication, if there are critical errors, they should be corrected as Corrigendum or Erratum.

September 2021, 16 (2)